B CELL DIFFERENTIATION IN IG TRANSGENIC SCID MICE
B CELL DIFFERENTIATION IN IG TRANSGENIC SCID MICE
批准号:
6337248
负责人:
MELVIN J BOSMA
金额:
$4.33万
依托单位国家:
美国
项目类别:
财政年份:
1983
资助国家:
美国
项目状态:
已结题
起止时间:
1983-12-01 至 2001-03-31
关键词:
B cell receptor B lymphocyte DNA damage SCID mouse animal breeding bromodeoxyuridine cell differentiation flow cytometry gene expression gene rearrangement genetically modified animals immunoglobulin genes polymerase chain reaction receptor binding recombinase subtraction hybridization tissue /cell culture
中文摘要
描述:这是第二次提交更新项目进行研究
免疫球蛋白转基因SCID小鼠B细胞分化的研究在……里面
在最近发表的初步实验中,研究人员发现
在转Ig重链基因的SCID小鼠中,B系细胞达到
前B细胞发育阶段,RAG1/2水平下调
亲B细胞阶段。在Ig重链和轻链基因转基因中,SCID B
谱系细胞可达到B细胞发育阶段和RAG1/2水平
在前B细胞阶段和前B细胞阶段都下调。数据来自
SCID/+和SCID转基因研究表明,仅重链基因就可以
阻止V-DJ加入活动(但不阻止DJ加入或V-Jkappa加入
事件),而重链和轻链基因阻止V-DJ连接和
Kappa轻链基因的重组也是如此。世界银行的目标是
目前的应用是:1)确定组装的重链基因如何
下调原B细胞中RAG的表达(和V-DJ连接)。会是
确定了伪轻链是否在该信号传递中起作用
将尝试克隆与信号传递有关的基因。2)
确定某些u/kappa基因组合促进SCID B细胞的原因
发展,而其他国家则不是。需要检验的一个假设是,这是否
是Mu,kappa组合能够阻止DNA的功能
导致SCID细胞DNA未解决断裂的重组事件。3)
探索Mu、kappa组合的抗原特异性
决定它是否会下调DNA重组(和RAG
表达)。4)确定免疫球蛋白中B细胞的发育是否加速
转基因小鼠。5)评估SCID B细胞的功能活性
转基因动物。值得注意的是,这些动物缺乏T细胞,就像RAG-/-小鼠一样,
但它们仍然是“漏水的”,允许低频率的Ig基因重排
去做吧。关于Ig分泌细胞的性质的问题将被问及
在这些小鼠中产生的(例如,表达kappa转基因或内源性kappa
基因?)以及B细胞是否具有抗自身免疫球蛋白转基因(dsDNA特异性)
能够在这些动物体内发育。6)亩、卡帕之间的差异
已经观察到了转基因SCID小鼠:其中一些小鼠的B细胞
对有丝分裂原有反应,而其他B细胞则不起作用。尝试次数将是
克隆基因,当差异表达时,允许
有丝分裂原反应性或有丝分裂原无反应性。
英文摘要
DESCRIPTION: This is a second submission of a renewal project to study
B-cell differentiation in immunoglobulin-transgenic scid mice. In
preliminary experiments recently published, the investigator has found that
in scid mice transgenic for Ig heavy chain genes, B lineage cells reach the
pre-B-cell stage of development and that RAG1/2 levels are downregulated at
the pro-B-cell stage. In Ig heavy and light chain gene transgenics, scid B
lineage cells can reach the B-cell stage of development and RAG1/2 levels
are down-regulated both at the pro-B and the pre-B-cell stages. Data from
scid/+ and scid transgenics suggest that the heavy chain gene, alone, can
prevent V-DJ joining events (but not DJ joining nor V-Jkappa joining
events), while heavy and light chain genes prevent V-DJ joining and
recombination at the kappa light chain locus, as well. The goals of the
present application are to: 1) determine how an assembled heavy chain gene
down-regulates RAG expression (and V-DJ joining) in pro-B-cells. It will be
determined whether pseudo-light chain plays a role in this signaling and
attempts will be made to clone genes involved in the signaling. 2)
Determine why some mu/kappa gene combinations work to promote scid B-cell
development while others do not. An hypothesis to be tested is whether this
is a function of the mu,kappa combination's being able to arrest DNA
recombination events which lead to unresolved breaks in scid cell DNA. 3)
Explore the notion that the antigen-specificity of the mu,kappa combination
determines whether it will down-regulate DNA recombination (and RAG
expression). 4) Determine whether B-cell development is accelerated in Ig
transgenic mice. 5) Assess the functional activity of scid B-cells in
transgenic animals. Notably, these animals lack T-cells, like RAG-/- mice,
but they remain "leaky," allowing low-frequency Ig gene rearrangements to
take place. Questions will be asked about the nature of Ig-secreting cells
that arise in these mice (e.g., express kappa transgene or endogenous kappa
genes?) and whether B-cells with anti-self Ig transgenes (dsDNA-specificity)
are able to develop in these animals. 6) Differences among mu,kappa
transgenic scid mice have already been observed: the B-cells in some are
responsive to mitogen while the B-cells in others are not. Attempts will be
made to clone the genes that, when differentially expressed, allow for
mitogen-responsiveness or mitogen-unresponsiveness, respectively.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CORE--HYBRIDOMA
-
批准号:6652211
-
项目类别:
-
资助金额:$19.62万
-
财政年份:2002
-
负责人:MELVIN J BOSMA
-
依托单位:
CORE--HYBRIDOMA
-
批准号:6485977
-
项目类别:
-
资助金额:$19.62万
-
财政年份:2001
-
负责人:MELVIN J BOSMA
-
依托单位:
CORE--HYBRIDOMA
-
批准号:6395549
-
项目类别:
-
资助金额:$24.85万
-
财政年份:1999
-
负责人:MELVIN J BOSMA
-
依托单位:
CORE--HYBRIDOMA
-
批准号:6395522
-
项目类别:
-
资助金额:$26.14万
-
财政年份:1999
-
负责人:MELVIN J BOSMA
-
依托单位:
CORE--HYBRIDOMA
-
批准号:6101389
-
项目类别:
-
资助金额:$26.14万
-
财政年份:1999
-
负责人:MELVIN J BOSMA
-
依托单位:
CORE--HYBRIDOMA
-
批准号:6398216
-
项目类别:
-
资助金额:$26.14万
-
财政年份:1999
-
负责人:MELVIN J BOSMA
-
依托单位:
CORE--HYBRIDOMA
-
批准号:6396690
-
项目类别:
-
资助金额:$26.14万
-
财政年份:1999
-
负责人:MELVIN J BOSMA
-
依托单位:
CORE--HYBRIDOMA
-
批准号:6268545
-
项目类别:
-
资助金额:$24.85万
-
财政年份:1998
-
负责人:MELVIN J BOSMA
-
依托单位:
CORE--HYBRIDOMA
-
批准号:6295720
-
项目类别:
-
资助金额:$24.85万
-
财政年份:1998
-
负责人:MELVIN J BOSMA
-
依托单位:
CORE--HYBRIDOMA
-
批准号:6235941
-
项目类别:
-
资助金额:$24.2万
-
财政年份:1997
-
负责人:MELVIN J BOSMA
-
依托单位:
SEVERE COMBINED IMMUNODEFICIENCY IN THE MOUSE
-
批准号:3481602
-
项目类别:
-
资助金额:$50.64万
-
财政年份:1983
-
负责人:MELVIN J BOSMA
-
依托单位:
B CELL DIFFERENTIATION IN IG TRANSGENIC SCID MICE
-
批准号:2894320
-
项目类别:
-
资助金额:$55.35万
-
财政年份:1983
-
负责人:MELVIN J BOSMA
-
依托单位:
B CELL DIFFERENTIATION IN IG TRANSGENIC SCID MICE
-
批准号:2390592
-
项目类别:
-
资助金额:$51.55万
-
财政年份:1983
-
负责人:MELVIN J BOSMA
-
依托单位:
SEVERE COMBINED IMMUNODEFICIENCY
-
批准号:3481599
-
项目类别:
-
资助金额:$34.83万
-
财政年份:1983
-
负责人:MELVIN J BOSMA
-
依托单位:
SEVERE COMBINED IMMUNODEFICIENCY
-
批准号:3481598
-
项目类别:
-
资助金额:$33.7万
-
财政年份:1983
-
负责人:MELVIN J BOSMA
-
依托单位:
SEVERE COMBINED IMMUNODEFICIENCY IN THE MOUSE
-
批准号:2084501
-
项目类别:
-
资助金额:$50.63万
-
财政年份:1983
-
负责人:MELVIN J BOSMA
-
依托单位:
SEVERE COMBINED IMMUNODEFICIENCY IN THE MOUSE
-
批准号:3481596
-
项目类别:
-
资助金额:$2.3万
-
财政年份:1983
-
负责人:MELVIN J BOSMA
-
依托单位:
Control of Ig Gene Expression in Ig Transgenic Mice
-
批准号:6632811
-
项目类别:
-
资助金额:$55.4万
-
财政年份:1983
-
负责人:MELVIN J BOSMA
-
依托单位:
SEVERE COMBINED IMMUNODEFICIENCY IN THE MOUSE
-
批准号:3481601
-
项目类别:
-
资助金额:$41.33万
-
财政年份:1983
-
负责人:MELVIN J BOSMA
-
依托单位:
SEVERE COMBINED IMMUNODEFICIENCY IN THE MOUSE
-
批准号:3481595
-
项目类别:
-
资助金额:$33.5万
-
财政年份:1983
-
负责人:MELVIN J BOSMA
-
依托单位:
海外基金